Back
Aptevo Therapeutics Quote, Financials, Valuation and Earnings
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
APVO
Aptevo Therapeutics
Last Price:
10.00
Seasonality Move:
-25.1%
7 Day Trial
ALL ACCESS PASS
$
7
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Aptevo Therapeutics Price Quote
$10.00
+1.31 (+15.01%)
(Updated: December 4, 2024 at 5:55 PM ET)
Aptevo Therapeutics Key Stats
Buy
51
Aptevo Therapeutics (APVO)
is a Buy
Day range:
$8.51 - $9.12
52-week range:
$5.11 - $399.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
72.83
P/B ratio:
0.98%
Volume:
45.5K
Avg. volume:
204.3K
1-year change:
-97.19%
Market cap:
$4.4M
Revenue:
$0
EPS:
$-3598.3
How Much Does Aptevo Therapeutics Make?
Data Unavailable
Is Aptevo Therapeutics Growing As A Company?
Data Unavailable
Aptevo Therapeutics Stock Price Performance
-
Did Aptevo Therapeutics Stock Go Up Last Month?
Aptevo Therapeutics share price went down by -5.24% last month -
Did APVO's Share Price Rise Over The Last Year?
APVO share price fell by -97.19% over the past 1 year
What Is Aptevo Therapeutics 52-Week High & Low?
-
What Is Aptevo Therapeutics’s 52-Week High Share Price?
Aptevo Therapeutics has traded as high as $399.60 over the past 52 weeks -
What Is Aptevo Therapeutics’s 52-Week Low Share Price?
Aptevo Therapeutics has traded as low as $5.11 over the past 52 weeks
Aptevo Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aptevo Therapeutics?
-
How Much Debt Does Aptevo Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aptevo Therapeutics Have?
Cash and short term investments quarterly total is $7.8M -
What Is Aptevo Therapeutics’s Book Value Per Share?
Book value per share is 9.59
Is Aptevo Therapeutics Cash Flow Positive?
-
What Is APVO Cash Flow From Operations?
Cash flow from operations (TTM) is -$23.3M -
What Is Aptevo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $11.9M -
What Is Aptevo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Aptevo Therapeutics Return On Invested Capital
Data Unavailable
Aptevo Therapeutics Earnings Date & Stock Price
-
What Is Aptevo Therapeutics's Stock Price Today?
A single share of APVO can be purchased today for 8.70 -
What Is Aptevo Therapeutics’s Stock Symbol?
Aptevo Therapeutics trades on the nasdaq under the ticker symbol: APVO -
When Is Aptevo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Aptevo Therapeutics is scheduled on March 5, 2025 -
When Is APVO's next ex-dividend date?
Aptevo Therapeutics's next ex-dividend date is May 15, 2020 -
How To Buy Aptevo Therapeutics Stock?
You can buy Aptevo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aptevo Therapeutics Competitors
-
Who Are Aptevo Therapeutics's Competitors?
Below is a list of companies who compete with Aptevo Therapeutics or are related in some way:
Aptevo Therapeutics Dividend Yield
-
What Is APVO Dividend Yield?
Aptevo Therapeutics’s dividend yield currently is 0% -
What Is Aptevo Therapeutics’s Payout Ratio?
Aptevo Therapeutics’s payout ratio is 0% -
When Did Aptevo Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 5, 2024 -
What Is Aptevo Therapeutics’s Dividend Per Share?
Aptevo Therapeutics pays a dividend of $0.00 per share
Aptevo Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 15.79% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 8.00 |
| Downside from Last Price: | -7.99% |